Famvir (Famciclovir)

What is Famvir?

Famvir (famciclovir) is an oral antiviral prescription medicine authorised under product- and country-specific conditions for the treatment of infections caused by herpes simplex virus (HSV-1 and HSV-2) and varicella-zoster virus (VZV). In the context of sexual health, it is used to treat genital herpes outbreaks and as suppressive therapy to reduce recurrence; transmission can still occur.

Famciclovir is a prodrug — it is converted in the body to its active form, penciclovir, which exerts the antiviral effect. It is well established in clinical practice alongside valacyclovir (Valtrex) and aciclovir (Zovirax) as one of the three main antiviral options for herpes infections.

How does Famvir work?

After oral administration, famciclovir undergoes rapid first-pass metabolism to penciclovir, its active antiviral metabolite.

The mechanism proceeds as follows:

1. Viral thymidine kinase phosphorylation: Penciclovir enters cells infected with herpes virus. The viral enzyme thymidine kinase (TK) — present in infected cells but not in uninfected human cells — phosphorylates penciclovir to penciclovir monophosphate.
2. Further phosphorylation: Cellular kinases convert penciclovir monophosphate to penciclovir triphosphate, the active form.
3. DNA polymerase inhibition: Penciclovir triphosphate competitively inhibits the viral DNA polymerase, the enzyme responsible for replicating viral DNA, preventing the virus from reproducing.
4. Selective activity: Because viral TK selectively activates penciclovir in infected cells, the drug’s antiviral effect is concentrated where the virus is active, limiting effects on normal cells.

Key pharmacokinetic feature: Penciclovir has a long intracellular half-life (7–20 hours in HSV-infected cells), which may allow for less frequent dosing compared to aciclovir.

Who is Famvir for?

Famvir is indicated for adults with herpes simplex and herpes zoster infections:

Sexual health indications:

• First episode of genital herpes (HSV-1 or HSV-2): Reduces severity and duration of the initial episode
• Recurrent genital herpes: Episodic treatment to shorten outbreak duration when started early
• Suppressive therapy: Continuous daily treatment to reduce frequency of recurrent outbreaks; a transmission-prevention benefit must not be assumed
• Orolabial herpes (cold sores): Not an authorised indication in the Spanish Famvir product information

Other indications:

• Herpes zoster (shingles): Reduces duration and severity of acute shingles and post-herpetic neuralgia when started within 72 hours of rash onset
• Herpes zoster ophthalmicus: Shingles affecting the eye area — under specialist supervision

Famvir is not effective against:

• HIV and other retroviruses
• Bacterial, fungal, or other infections
• HPV (genital warts, cervical infection)

Dosage

For a first episode of genital herpes in adults with a normal immune system, the EU product information gives famciclovir 250 mg three times a day for 5 days, started as soon as possible after diagnosis. For a recurrent episode it gives 125 mg twice a day for 5 days, started as soon as possible after the first warning signs (tingling, itching, burning or pain) or sores. To prevent recurrences it gives 250 mg twice a day, reviewed after no more than 12 months. Doses differ if your immune system is weakened or your kidneys work less well. The doctor decides whether famciclovir is suitable and at what dose.

Important: Dose reduction is required in patients with reduced kidney function (renal impairment). A doctor will calculate the appropriate dose based on kidney function test results.

Famvir tablets can be taken with or without food.

Side effects

Famvir is generally well tolerated. Side effects are similar to other oral antiviral medicines used for herpes.

Very common side effects (at least 1 in 10 people)

• Headache

Common side effects (at least 1 in 100 but fewer than 1 in 10 people)

• Nausea
• Diarrhoea
• Dizziness
• Abdominal pain
• Vomiting
• Pruritus (itching)
• Rash

Serious effects and warning signs

• Severe allergic reactions: Including anaphylaxis — seek immediate medical help if facial swelling, breathing difficulty, or collapse occurs
• Neurological effects: Confusion, hallucinations, and agitation — more common in elderly patients or those with renal impairment; stop treatment and seek urgent medical attention
• Haematological effects: Thrombocytopenia (low platelet count) — rare with standard doses
• Renal impairment: Adequate hydration is important; dose reduction is required in pre-existing renal impairment

Famvir vs alternative herpes antivirals

Clinical equivalence: All three antiviral options (famciclovir, valacyclovir, aciclovir) have similar clinical efficacy for treating herpes simplex and zoster infections. The choice is typically based on dosing frequency, patient preference, and cost.

• Famvir vs Valtrex: Both are prodrugs with similar efficacy and tolerability. Valacyclovir may offer slightly more convenient dosing for some indications.
• Famvir vs Zovirax: Aciclovir requires five doses per day for episodic treatment, making it less convenient than famciclovir or valacyclovir. However, aciclovir is often less expensive.

Online assessment for Famvir (Famciclovir)

Famvir is a prescription-only medicine (POM) in all EU member states. It cannot legally be dispensed without a valid prescription from a licensed medical professional.

Prescrivia operates as a technology intermediary: we do not prescribe medicines, employ doctors, or sell medicines. Our platform connects patients with independent doctors who can conduct confidential online health assessments.

Availability of an online assessment, prescribing, dispensing and delivery depends on the medicine, country and applicable law. Spain prohibits distance sale of prescription medicines; a catalogue entry or cross-border prescription does not establish a right to delivery. An in-person examination or testing may be required.

The process, where legally and clinically available:

1. Complete a health assessment: Describe your symptoms, history of herpes episodes, and any current medications or kidney problems.
2. Doctor review: An independent doctor reviews your assessment. If famciclovir is clinically appropriate, they may issue a prescription.
3. Pharmacy fulfilment: The prescription is sent to a pharmacy partner to assess dispensing and any supply under the applicable country rules.

Important: Prescrivia does not guarantee that a prescription will be issued. All prescribing decisions are made independently by qualified medical professionals.

Important safety information

Tell your doctor before taking Famvir if you:

• Have kidney disease (dose adjustment is required)
• Are pregnant or breastfeeding (limited data — a doctor must assess risk-benefit)
• Are immunocompromised (HIV, transplant medication, cancer treatment)
• Are elderly (increased risk of neurological side effects at higher doses)
• Are taking any other medicines, particularly those affecting kidney function

Transmission reduction: Famvir does not eliminate transmission risk, and evidence for another antiviral must not be assumed to establish the same transmission benefit for famciclovir. Consistent use of condoms provides additional risk reduction. Partners should be informed of herpes status to make informed decisions.

Resistance: Antiviral resistance to famciclovir/penciclovir is uncommon in immunocompetent individuals but may occur in immunocompromised patients on long-term therapy. A doctor should be consulted if treatment appears to be losing effectiveness.

Sources

• Product information / clinical reference 1

Medical information on this page is based on the following sources:

• World Health Organization (WHO). Herpes simplex virus — Fact sheet. who.int
• Gupta R, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. Journal of Infectious Diseases. 2004.
• Bodsworth NJ, et al. Famciclovir in the treatment of genital herpes. Antiviral Research. 1997.

The content-edit date does not certify a clinical review. It is provided for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for advice relevant to your individual health circumstances.